Cancer-prone cell states of the fallopian tubal epithelium
Cancer-prone cell states of the fallopian tubal epithelium
批准号:
10184438
负责人:
Alexander Y Nikitin
金额:
$42.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-05-01 至 2026-04-30
关键词:
BiologicalBreast CarcinomaCarcinomaCell LineageCellsCharacteristicsChargeClinicalConsensusDataDiagnosisDiseaseDissociationDistalEpithelialEpithelial CellsEpithelial ovarian cancerFrequenciesGenetic TranscriptionGenomicsGrowth FactorHeterogeneityHumanImplantInflammatoryMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of ovaryMammalian OviductsMechanicsMesenchymalModalityMolecular AbnormalityMolecular ProfilingMorphologyMusMutationNatural regenerationNeoplasm MetastasisOrganoidsOvarianOvarian CarcinomaPatientsPopulationPredispositionPrognostic MarkerProstate carcinomaReportingRoleSerousSignal TransductionStratificationStromal CellsStromal ChangeSurfaceSurvival RateSymptomsSystemTestingTubeWomanbasebiomarker developmentcancer cellcancer typecell typecellular developmentdiagnostic biomarkergenetic signatureimmunoreactivityinsightmutantnovel therapeuticsresponsestemstem cellstranscriptometranscriptomicstreatment responsetumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Ovarian/extra-uterine high-grade serous carcinoma (HGSC) is the most common and aggressive type of ovarian
cancer. It often has no symptoms at early stages and over 80% of patients are diagnosed at advanced, usually
incurable, cancer stages, when the tumors have already metastasized. Extensive integrated genomic analysis
allowed identification of several clinically distinct subtypes of HGSC. A significant fraction of HGSC arises from
the tubal epithelium (TE) located in the distal region of Fallopian tube (aka uterine tube or oviduct). Recent single
cell transcriptome analysis of distal TE inferred that HGSC heterogeneity could be connected to diverse cell
states present in TE cell lineages. Unfortunately, precise cell lineage-based hierarchy of identified TE cell types
has not been yet established. Furthermore, cancer-prone cellular states of TE are insufficiently defined and
factors influencing such states remain unclear. Thus, it remains unknown if uneven clinical course of HGSC and
development of cellular therapeutic responses may reflect different modes of initiation and progression of this
malignancy. Our preliminary studies show that, in addition to known secretory (OVGP1+) and ciliated (FOXJ1+,
CD24+) epithelial cells, there are several epithelial cell populations characterized by preferential expression of
stem/progenitor cell markers, such as SLC1A3, CD49f (ITGA6), and KLF6. A Monocle cell-lineage trajectory
prediction analysis of our single-cell transcriptomic data identified a population of SLC1A3+ stem/progenitor cells
that give rise to both secretory and ciliated cells by progressing through transient intermediates, including a
KRT5+ cell population. This prediction has been confirmed by lineage tracing of SLC1A3+ cells and ex vivo
studies. Cells in a transient state (CD24med CD49f+) form spheres in consecutive rounds of sphere dissociation-
regeneration and express KRT5. Under normal homeostatic conditions, KRT5+ cells are largely dormant and
minimally contribute to secretory and ciliated cell lineages. However, KRT5+ cells become actively involved in
re-epithelialization after mechanical damage. Our preliminary results suggest that stromal charges begin to co-
evolve with mutant epithelial cells before the earliest morphologically detectable alterations. Based on previous
studies and our preliminary results we hypothesize that cancer-prone TE cell states are determined by levels of
epithelial damage and stromal milieu changes. To test this hypothesis we propose (1) to establish the role of
specific cell states during homeostatic and posttraumatic regeneration, (2) to determine the impact of epithelial
damage on cancer susceptibility of epithelial states and (3) to identify and characterize epithelial and stromal cell
lineage dynamics during early stages of TE malignant transformation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cancer-prone cell states of the fallopian tubal epithelium
-
批准号:10397606
-
项目类别:
-
资助金额:$42.09万
-
财政年份:2021
-
负责人:Alexander Y Nikitin
-
依托单位:
Endometrial epithelial stem cells and cancer
-
批准号:10621932
-
项目类别:
-
资助金额:$42.52万
-
财政年份:2021
-
负责人:Alexander Y Nikitin
-
依托单位:
Endometrial epithelial stem cells and cancer
-
批准号:10413820
-
项目类别:
-
资助金额:$42.52万
-
财政年份:2021
-
负责人:Alexander Y Nikitin
-
依托单位:
Cancer-prone cell states of the fallopian tubal epithelium
-
批准号:10625966
-
项目类别:
-
资助金额:$42.09万
-
财政年份:2021
-
负责人:Alexander Y Nikitin
-
依托单位:
Neuroendocrine mechanisms of prostate cancer progression
-
批准号:9291444
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2015
-
负责人:Alexander Y Nikitin
-
依托单位:
Neuroendocrine mechanisms of prostate cancer progression
-
批准号:10245737
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2015
-
负责人:Alexander Y Nikitin
-
依托单位:
Origins of Ovarian Carcinoma
-
批准号:9257361
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2015
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling ovarian carcinoma by defined genetic alterations
-
批准号:7666760
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2005
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling ovarian carcinoma by defined genetic alterations
-
批准号:6983701
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2005
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling ovarian carcinoma by defined genetic alterations
-
批准号:7118757
-
项目类别:
-
资助金额:$29.48万
-
财政年份:2005
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling ovarian carcinoma by defined genetic alterations
-
批准号:7255706
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2005
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling ovarian carcinoma by defined genetic alterations
-
批准号:7436299
-
项目类别:
-
资助金额:$26.63万
-
财政年份:2005
-
负责人:Alexander Y Nikitin
-
依托单位:
Determinants of Metastatic Progression
-
批准号:7316372
-
项目类别:
-
资助金额:$28.74万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
Determinants of Metastatic Progression
-
批准号:7665055
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
ADVANCING MENTORING AND RESEARCH IN MOUSE PATHOBIOLOGY
-
批准号:7124319
-
项目类别:
-
资助金额:$10.04万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling metastasis by controlled inactivation of Rb
-
批准号:7086186
-
项目类别:
-
资助金额:$27.64万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling metastasis by controlled inactivation of Rb
-
批准号:6513929
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
Determinants of Metastatic Progression
-
批准号:8265011
-
项目类别:
-
资助金额:$26.15万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
ADVANCING MENTORING AND RESEARCH IN MOUSE PATHOBIOLOGY
-
批准号:6668580
-
项目类别:
-
资助金额:$9.18万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
Modeling metastasis by controlled inactivation of Rb
-
批准号:6766694
-
项目类别:
-
资助金额:$28.3万
-
财政年份:2002
-
负责人:Alexander Y Nikitin
-
依托单位:
海外基金